<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmacytimes.com/view/rebuilding-vaccine-confidence-a-pharmacist-s-field-guide</loc>
      <lastmod>2026-11-19T17:40:45.974Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:40:45.974Z</news:publication_date>
        <news:title><![CDATA[Rebuilding Vaccine Confidence: A Pharmacist’s Field Guide]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/enzyme-replacement-in-pancreatic-cancer-what-pharmacists-should-know</loc>
      <lastmod>2026-11-19T17:34:57.436Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:34:57.436Z</news:publication_date>
        <news:title><![CDATA[Enzyme Replacement in Pancreatic Cancer: What Pharmacists Should Know]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/a-pharmacist-s-checklist-for-coordinating-care</loc>
      <lastmod>2026-11-19T17:26:37.766Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:26:37.766Z</news:publication_date>
        <news:title><![CDATA[A Pharmacist's Checklist for Coordinating Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/male-mice-develop-more-severe-zika-neurological-disease-despite-comparable-viral-loads</loc>
      <lastmod>2026-11-19T17:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Male Mice Develop More Severe Zika Neurological Disease Despite Comparable Viral Loads]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/cemdisiran-approved-as-first-sirna-therapy-for-myasthenia-gravis</loc>
      <lastmod>2026-11-19T15:29:07.907Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T15:29:07.907Z</news:publication_date>
        <news:title><![CDATA[Cemdisiran Approved as First siRNA Therapy for Myasthenia Gravis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/do-you-have-a-millionaire-mindset-</loc>
      <lastmod>2026-11-19T14:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Do You Have a Millionaire Mindset?]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/managing-postpartum-psychosis-through-lithium-based-treatment-screening-and-team-based-care</loc>
      <lastmod>2026-11-19T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing Postpartum Psychosis Through Lithium-Based Treatment, Screening, and Team-Based Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/biomarker-testing-delays-in-nsclc-tissue-liquid-biopsy-and-treatment-start</loc>
      <lastmod>2026-11-19T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Biomarker Testing Delays in NSCLC: Tissue, Liquid Biopsy, and Treatment Start]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/speeding-up-nsclc-treatment-ai-scheduling-subcutaneous-dosing-and-payer-transparency</loc>
      <lastmod>2026-11-19T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Speeding Up NSCLC Treatment: AI Scheduling, Subcutaneous Dosing, and Payer Transparency]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-venglustat-first-treatment-for-neurological-symptoms-of-gd3</loc>
      <lastmod>2026-11-19T15:37:48.731Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T22:05:18.561Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Venglustat, First Treatment for Neurological Symptoms of GD3]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/asra-case-highlights-when-to-reassess-cannabis-use-for-chronic-pain</loc>
      <lastmod>2026-11-18T21:45:37.197Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:45:37.197Z</news:publication_date>
        <news:title><![CDATA[ASRA Case Highlights When to Reassess Cannabis Use for Chronic Pain ]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/from-awareness-to-action-pharmacists-advancing-antibiotic-stewardship</loc>
      <lastmod>2026-11-18T21:32:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:32:00Z</news:publication_date>
        <news:title><![CDATA[From Awareness to Action: Pharmacists Advancing Antibiotic Stewardship]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/galinpepimut-s-cuts-risk-of-death-by-41-in-phase-3-regal-trial</loc>
      <lastmod>2026-11-18T21:19:13.411Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:19:13.411Z</news:publication_date>
        <news:title><![CDATA[Galinpepimut-S Cuts Risk of Death by 41% in Phase 3 REGAL Trial]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/continuous-glucose-monitoring-for-patient-empowerment-and-medication-optimization</loc>
      <lastmod>2026-11-18T18:46:37.840Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T18:46:37.840Z</news:publication_date>
        <news:title><![CDATA[Continuous Glucose Monitoring for Patient Empowerment and Medication Optimization]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacist-checklist-a-quick-reference-guide-for-multidisciplinary-stroke-prevention-rounds</loc>
      <lastmod>2026-11-18T17:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T17:00:00Z</news:publication_date>
        <news:title><![CDATA[A Quick-Reference Guide for Multidisciplinary Stroke Prevention Rounds]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expanding-career-pathways-in-pharmacy-education</loc>
      <lastmod>2026-11-18T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Expanding Career Pathways in Pharmacy Education]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-can-address-diabetes-self-management-barriers</loc>
      <lastmod>2026-11-18T15:50:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T15:50:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacists Can Address Diabetes Self-Management Barriers]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacist-led-initiative-enrolling-medicare-eligible-patients-in-state-pharmaceutical-assistance-programs</loc>
      <lastmod>2026-11-18T15:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacist-Led Initiative Enrolling Medicare-Eligible Patients in State Pharmaceutical Assistance Programs]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/long-acting-hiv-injectables-in-viremia-and-new-tenofovir-free-oral-options</loc>
      <lastmod>2026-11-18T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Long-Acting HIV Injectables in Viremia and New Tenofovir-Free Oral Options]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ponatinib-in-ph-all-translating-clinical-value-into-treatment-decisions</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Ponatinib in Ph+ ALL: Translating Clinical Value Into Treatment Decisions]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/two-drug-hiv-regimens-archived-m184v-resistance-and-long-acting-preference</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Two-Drug HIV Regimens, Archived M184V Resistance, and Long-Acting Preference]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-grants-accelerated-approval-to-neladalkib-for-previously-treated-alk-positive-nsclc</loc>
      <lastmod>2026-11-17T20:22:36.824Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:22:36.824Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLC]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/adrabetadex-becomes-first-therapy-shown-to-extend-survival-in-infantile-onset-niemann-pick-disease-type-c</loc>
      <lastmod>2026-11-17T20:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:05:00Z</news:publication_date>
        <news:title><![CDATA[Adrabetadex Becomes First Therapy Shown to Extend Survival in Infantile-Onset Niemann-Pick Disease Type C]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/managing-survodutide-gi-adverse-effects-the-pharmacist-s-role</loc>
      <lastmod>2026-11-17T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing Survodutide GI Adverse Effects: The Pharmacist's Role]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/enlicitide-in-primary-prevention-what-prevent-data-show</loc>
      <lastmod>2026-11-17T19:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Enlicitide in Primary Prevention: What PREVENT Data Show]]></news:title>
      </news:news>
	</url></urlset>